Pharmacokinetic study of BSH and BPA in simultaneous use for BNCT

Journal of Neuro-Oncology

Volumn 78, Issue 3, 2006, Pages 227-232

  Yokoyama, Kunio ^a   Miyatake, Shin Ichi ^a   Kajimoto, Yoshinaga ^a   Kawabata, Shinji ^a   Doi, Atsushi ^a   Yoshida, Toshiko ^b   Asano, Tomoyuki ^c   Kirihata, Mitsunori ^c   Ono, Koji ^d   Kuroiwa, Toshihiko ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

^b UNIVERSITY OF TOYAMA   (Japan)

^c Osaka Prefecture University   (Japan)

^d KYOTO UNIVERSITY   (Japan)

Author keywords

BNCT; BPA; BSH; Glioma; ICP AES

Indexed keywords

4 BORONOPHENYLALANINE; BOROCAPTATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATOMIC EMISSION SPECTROMETRY; BLOOD SAMPLING; BRAIN TUMOR; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG DOSE REGIMEN; GLIOBLASTOMA; MALE; NEUTRON CAPTURE THERAPY; NONHUMAN; QUANTITATIVE ANALYSIS; RAT; SURVIVAL RATE;

ANIMALS; BOROHYDRIDES; BORON COMPOUNDS; BORON NEUTRON CAPTURE THERAPY; BRAIN; BRAIN NEOPLASMS; DRUG COMBINATIONS; DRUG SYNERGISM; GLIOMA; MALE; PHENYLALANINE; RADIATION-SENSITIZING AGENTS; RADIOTHERAPY DOSAGE; RATS; RATS, WISTAR; STATISTICS, NONPARAMETRIC; SULFHYDRYL COMPOUNDS;

EID: 33745778450     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-005-9099-4     Document Type: Article

References (22)

1. Taylor HJ, Goldhaber M, 1935. Detection of nuclear disintegration in a photographic emulsion Nature 135: 341
2. Barth RF, Soloway AH, Fairchild RG, 1992. Boron neutron capture therapy for cancer Cancer 70: 2995-3007
3. Coderre JA, Morris GM, 1999. The radiation biology of boron neutron capture therapy Radiat Res 151: 1-18
4. Soloway AH, Tjarks W, Barnum BA, Rong FG, Barth RF, Codogni IM, Wilson JG, 1998. The chemistry of neutron capture therapy Chem Rev 98: 1515-1562
5. Kageji T, Nagahiro S, Kitamura K, Nakagawa Y, Hatanaka H, 2001. Optimal timing of neutron irradiation for boron neutron capture therapy after intravenous infusion of sodium borocaptate in patients with glioblastoma Int J Radiation Oncology Biol Phy 51: 120-130
6. Mahta SC, Lu DR, 1996. Targeted drug delivery for boron neutron capture therapy Pharm Res 13: 344-351
7. Barth RF, Soloway AH, Goodman JH, Gahbauer RA, Gupta N, Blue TE, Yang W, Tjarks W, 1999. Boron neutron capture therapy of brain tumors: An emerging therapeutic modality Neurosurgery 44: 433-450
8. Mishima Y, 1996. Selective thermal neutron capture therapy of cancer cells using their specific metabolic activities-melanoma as prototype. In: Mishima Y, (eds). Cancer Neutron Capture Therapy. Plenum Press, New York, 1-26
9. Snyder HR, Reedy AJ, Lennarz WJ, 1958. Synthesis of aromatic boronic acids, aldehydo boronic acids and a boronic acid analog of tyrosine J Am Chem Soc 80: 835-838
10. Soloway AH, Hatanaka H, Davis MA, 1967. Penetration of brain and brain tumor: 7-Tumor-binding sulfhydryl boron compounds J Med Chem 10: 714-717
11. 11SH) in patients with intracranial tumors J Neuro-Oncol 33: 117-130
12. Kawabata S, Miyatake S, Kajimoto Y, Kuroda Y, Kuroiwa T, Imahori Y, Kirihata M, Sakurai Y, Kobayashi T, Ono K, 2003. The early successful treatment of glioblastoma patients with modified boron neutron capture therapy. Report of two cases J Neuro-Oncol 65: 159-65
13. Miyatake S, Kuwabara H, Kazimoto Y, Kawabata S, Yokoyama K, Doi A, Tsuji M, Mori H, Ono K, Kuroiwa T: Preferential recurrence of a sarcomatous component of a gliosarcoma after boron neutron capture therapy: Case report. J Neuro-Oncol, 15 Epublication ahead of print, 2005
14. Miyatake S, Kawabata S, Kajimoto Y, Aoki A, Yokoyama K, Yamada M, Kuroiwa T, Tsuji M, Imahori Y, Kirihata M, Sakurai Y, Masunaga S, Nagata K, Maruhashi A, Ono K, 2005. Modified boron neutron capture therapy for malignant gliomas performed using epithermal neutron and two boron compounds with different accumulation mechanisms: An efficacy study based on findings on neuroimages J Neurosurgery 103: 1000-1009
15. Joel DD, Coderre JA, Micca PL, Nawrocky MM, 1999. Effect of dose and infusion time on the delivery of p -boronophenylalanine for neutron capture therapy J Neuro-Oncol 41: 213-221
16. Barth RF: Sodium borocaptate and boronopheynlalanine alone or in combination as capture agents for BNCT of the F98 rat glioma. In: Mishima Y (ed) Cancer Neutron Capture Therapy. Plenum Press, New York, 1996, pp 769-775
17. Chandra S, Lorey DR, Smith DR, 2002. Quantitative subcellular secondary ion mass spectrometry (SIMS) imaging of boron-10 and boron-11 isotopes in the same cell delivered by two combined BNCT drugs: In vitro studies on human glioblastoma T98G cells Radiat Res 157: 700-710
18. Smith DR, Chandra S, Barth RF, Yang W, Joel DD, Coderre JA, 2001. Quantitative imaging and microlocalization of boron-10 in brain tumors and infiltrating tumor cells by SIMS ion microscopy: Relative to neutron capture therapy Cancer Res 61: 8179-8187
19. Oyedepo AC, Brooke SL, Heard PJ, Day JCC, Allen GC, Pate H, 2004. Analysis of boron-10 in soft tissue by dynamic secondary ion mass spectrometry J Microsc 213: 39-45
20. Ono K, Masunaga S, Suzuki M, Kinashi Y, Takagaki M, Akaboshi M, 1999. The Combined Effect of Boronophenylalanine and Borocaptate in Boron Neutron Capture Therapy for SCCVII Tumors in Mice Int J Radiat Oncol Biol Phys 43(2): 431-436
21. Ono K, Masunaga S, Kinashi Y, Takagaki M, Akaboshi M, Kobayashi T, Akuta K, 1996. Radiobiological evidence suggesting heterogeneous microdistribution of boron compounds in tumors: Its relation to quiescent cell population and tumor cure in neutron capture therapy Int J Radiat Oncol Biol Phys 34(5): 1081-1086
22. Yoshida F, Matsumura A, Shibata Y, Yamamoto T, Nakauchi H, Okumura M, Nose T, 2002. Cell cycle dependence of boron uptake from two boron compounds used for clinical neutron capture therapy Cancer lett 187: 135-141